Royal Bank Of Canada Esperion Therapeutics, Inc. Transaction History

Royal Bank Of Canada

$528 Billion
Q2 2025

A detailed history of Royal Bank Of Canada transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 1,166,521 shares of ESPR stock, worth $2.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,166,521

Previous 6,675 17375.97%

Holding current value

$2.09 Million

Previous $9,000 12600.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$0.73 - $1.41 $846,687 - $1.64 Million	1,159,846 Added 17375.97%	1,166,521 $1.14 Million
Q1 2025 May 15, 2025	SELL	$1.44 - $2.34 $16,858 - $27,394	-11,707 Reduced 63.69%	6,675 $9,000
Q4 2024 Feb 14, 2025	SELL	$1.61 - $3.83 $1,896 - $4,511	-1,178 Reduced 6.02%	18,382 $40,000
Q3 2024 Nov 14, 2024	SELL	$1.61 - $2.73 $205,300 - $348,118	-127,516 Reduced 86.7%	19,560 $32,000
Q2 2024 Aug 14, 2024	BUY	$1.84 - $3.24 $190,035 - $334,627	103,280 Added 235.82%	147,076 $326,000
Q1 2024 Nov 05, 2024	SELL	$2.02 - $3.02 $208,625 - $311,905	-103,280 Reduced 70.22%	43,796 $117,000
Q4 2023 Feb 14, 2024	BUY	$0.73 - $3.08 $24,646 - $103,990	33,763 Added 336.52%	43,796 $130,000
Q3 2023 Nov 14, 2023	SELL	$0.96 - $1.79 $6,854 - $12,780	-7,140 Reduced 41.58%	10,033 $9,000
Q2 2023 Aug 14, 2023	SELL	$1.2 - $1.76 $6,066 - $8,896	-5,055 Reduced 22.74%	17,173 $23,000
Q1 2023 May 15, 2023	BUY	$1.46 - $7.3 $4,162 - $20,812	2,851 Added 14.71%	22,228 $35,000
Q4 2022 Feb 14, 2023	BUY	$5.09 - $8.5 $90,546 - $151,206	17,789 Added 1120.21%	19,377 $120,000
Q3 2022 Nov 14, 2022	BUY	$5.45 - $8.13 $2,474 - $3,691	454 Added 40.04%	1,588 $10,000
Q2 2022 Aug 15, 2022	SELL	$4.77 - $6.67 $15,211 - $21,270	-3,189 Reduced 73.77%	1,134 $7,000
Q1 2022 May 16, 2022	SELL	$3.34 - $5.56 $4,933 - $8,212	-1,477 Reduced 25.47%	4,323 $19,000
Q4 2021 Feb 14, 2022	BUY	$4.81 - $11.92 $485 - $1,203	101 Added 1.77%	5,800 $29,000
Q3 2021 Nov 15, 2021	SELL	$11.34 - $21.37 $9,650 - $18,185	-851 Reduced 12.99%	5,699 $67,000
Q2 2021 Aug 16, 2021	BUY	$19.4 - $28.71 $127,069 - $188,050	6,550 New	6,550 $140,000

Others Institutions Holding ESPR

# of Institutions

183

Shares Held

106M

Call Options Held

139K

Put Options Held

604K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $119M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Esperion Therapeutics, Inc. Transaction History